Intuitive Surgical Competitors

Abbott Laboratories (NYSE:ABT) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings and target prices for Abbott Laboratories and Intuitive Surgical, as provided by MarketBeat.com.

Abbott Laboratories currently has a consensus price target of $115.6875, suggesting a potential upside of 0.84%. Intuitive Surgical has a consensus price target of $736.0588, suggesting a potential downside of 2.12%. Given Abbott Laboratories' stronger consensus rating and higher possible upside, equities analysts plainly believe Abbott Laboratories is more favorable than Intuitive Surgical.

Risk and Volatility

Abbott Laboratories has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500.

Profitability

This table compares Abbott Laboratories and Intuitive Surgical's net margins, return on equity and return on assets.

Insider and Institutional Ownership

72.6% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 86.5% of Intuitive Surgical shares are owned by institutional investors. 1.7% of Abbott Laboratories shares are owned by company insiders. Comparatively, 1.6% of Intuitive Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Abbott Laboratories and Intuitive Surgical's top-line revenue, earnings per share (EPS) and valuation.

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Intuitive Surgical (NASDAQ:ISRG) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for Intuitive Surgical and Medtronic, as provided by MarketBeat.

Intuitive Surgical currently has a consensus price target of $736.0588, suggesting a potential downside of 2.12%. Medtronic has a consensus price target of $122.2963, suggesting a potential upside of 4.62%. Given Medtronic's stronger consensus rating and higher probable upside, analysts plainly believe Medtronic is more favorable than Intuitive Surgical.

Profitability

This table compares Intuitive Surgical and Medtronic's net margins, return on equity and return on assets.

Risk and Volatility

Intuitive Surgical has a beta of 0.98, indicating that its share price is 2% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500.

Institutional & Insider Ownership

86.5% of Intuitive Surgical shares are held by institutional investors. Comparatively, 79.2% of Medtronic shares are held by institutional investors. 1.6% of Intuitive Surgical shares are held by insiders. Comparatively, 0.5% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Intuitive Surgical and Medtronic's gross revenue, earnings per share (EPS) and valuation.

Medtronic has higher revenue and earnings than Intuitive Surgical. Medtronic is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Summary

Intuitive Surgical beats Medtronic on 9 of the 15 factors compared between the two stocks.

Stryker (NYSE:SYK) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Profitability

This table compares Stryker and Intuitive Surgical's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current recommendations for Stryker and Intuitive Surgical, as provided by MarketBeat.com.

Stryker currently has a consensus price target of $227.4783, indicating a potential downside of 5.04%. Intuitive Surgical has a consensus price target of $736.0588, indicating a potential downside of 2.12%. Given Intuitive Surgical's higher possible upside, analysts clearly believe Intuitive Surgical is more favorable than Stryker.

Insider and Institutional Ownership

71.5% of Stryker shares are owned by institutional investors. Comparatively, 86.5% of Intuitive Surgical shares are owned by institutional investors. 6.8% of Stryker shares are owned by insiders. Comparatively, 1.6% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Stryker and Intuitive Surgical's revenue, earnings per share and valuation.

Stryker has higher revenue and earnings than Intuitive Surgical. Stryker is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Stryker has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500.

Summary

Intuitive Surgical beats Stryker on 8 of the 15 factors compared between the two stocks.

Becton, Dickinson and (NYSE:BDX) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Institutional & Insider Ownership

83.2% of Becton, Dickinson and shares are held by institutional investors. Comparatively, 86.5% of Intuitive Surgical shares are held by institutional investors. 0.8% of Becton, Dickinson and shares are held by company insiders. Comparatively, 1.6% of Intuitive Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Becton, Dickinson and and Intuitive Surgical's net margins, return on equity and return on assets.

Risk and Volatility

Becton, Dickinson and has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Becton, Dickinson and and Intuitive Surgical, as reported by MarketBeat.

Becton, Dickinson and currently has a consensus price target of $279.6667, indicating a potential upside of 7.46%. Intuitive Surgical has a consensus price target of $736.0588, indicating a potential downside of 2.12%. Given Becton, Dickinson and's stronger consensus rating and higher probable upside, analysts plainly believe Becton, Dickinson and is more favorable than Intuitive Surgical.

Valuation & Earnings

This table compares Becton, Dickinson and and Intuitive Surgical's gross revenue, earnings per share (EPS) and valuation.

Intuitive Surgical has lower revenue, but higher earnings than Becton, Dickinson and. Becton, Dickinson and is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Summary

Intuitive Surgical beats Becton, Dickinson and on 8 of the 14 factors compared between the two stocks.

Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.

Insider and Institutional Ownership

80.9% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 86.5% of Intuitive Surgical shares are owned by institutional investors. 1.5% of Edwards Lifesciences shares are owned by insiders. Comparatively, 1.6% of Intuitive Surgical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk & Volatility

Edwards Lifesciences has a beta of 0.97, suggesting that its share price is 3% less volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for Edwards Lifesciences and Intuitive Surgical, as provided by MarketBeat.com.

Edwards Lifesciences currently has a consensus price target of $90.8704, suggesting a potential upside of 5.80%. Intuitive Surgical has a consensus price target of $736.0588, suggesting a potential downside of 2.12%. Given Edwards Lifesciences' stronger consensus rating and higher possible upside, equities research analysts plainly believe Edwards Lifesciences is more favorable than Intuitive Surgical.

Profitability

This table compares Edwards Lifesciences and Intuitive Surgical's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares Edwards Lifesciences and Intuitive Surgical's top-line revenue, earnings per share and valuation.

Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Summary

Intuitive Surgical beats Edwards Lifesciences on 9 of the 14 factors compared between the two stocks.

Intuitive Surgical (NASDAQ:ISRG) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Earnings & Valuation

This table compares Intuitive Surgical and Boston Scientific's gross revenue, earnings per share and valuation.

Boston Scientific has higher revenue and earnings than Intuitive Surgical. Boston Scientific is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and target prices for Intuitive Surgical and Boston Scientific, as provided by MarketBeat.com.

Intuitive Surgical presently has a consensus price target of $736.0588, suggesting a potential downside of 2.12%. Boston Scientific has a consensus price target of $43.0870, suggesting a potential upside of 17.15%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Boston Scientific is more favorable than Intuitive Surgical.

Institutional and Insider Ownership

86.5% of Intuitive Surgical shares are held by institutional investors. Comparatively, 90.7% of Boston Scientific shares are held by institutional investors. 1.6% of Intuitive Surgical shares are held by insiders. Comparatively, 0.7% of Boston Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Intuitive Surgical and Boston Scientific's net margins, return on equity and return on assets.

Volatility and Risk

Intuitive Surgical has a beta of 0.98, indicating that its stock price is 2% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.

Summary

Boston Scientific beats Intuitive Surgical on 8 of the 15 factors compared between the two stocks.